Airity Technologies

Stanford University, $25,000

This team is developing a cold plasma device that selectively kills infection-causing microorganisms without damage to other cells or tissues. The major benefit of this technology over current methods of disinfection is its potential effectiveness against the most robust infectious organisms, including drug-resistant bacterial strains, fungi and biofilms.


By continuing to use the site, you agree to the use of cookies. Read More

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close